Full Text View
Tabular View
Study Results
Related Studies
Two Rizatriptan Prescribing Portions for Treatment of Migraine
This study has been completed.
Study NCT00397254   Information provided by Clinvest

First Received on November 7, 2006.   Last Updated on June 7, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Migraine
Additional conditions recognized in this trial
Migraine Disorders
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Headache Disorders
Headache Disorders, Primary
Nervous System Diseases
Interventions listed in this trial
rizatriptan
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Serotonin Agents
Serotonin Receptor Agonists
Sponsors listed in this trial
Clinvest
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services